Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Acta Médica Peruana
versión On-line ISSN 1728-5917
Resumen
UGARTE-GIL, César; PONCE ALVAREZ, Mario y MOORE, David A. J.. Drug susceptibility tests for Mycobacterium tuberculosis. Acta méd. peruana [online]. 2008, vol.25, n.3, pp.171-175. ISSN 1728-5917.
Inadequate treatment regimens and poor compliance have led to increased rates of drug resistance in Mycobacterium tuberculosis around the world, leading to the emergence of multidrug resistant (MDR) and extensively drug resistant (XDR) strains. In Peru MDR-TB rates are amongst the highest in the world and XDR-TB cases have been reported for almost a decade. Drug susceptibility tests detect cases with resistant strains, providing the best treatment option to the patient and diminishing the spread of the disease. This review is directed at the non-specialist physician, focusing upon the drug susceptibility tests approved by the National TB Program of Peru and others currently still under research.
Palabras clave : tuberculosis; drug susceptibility tests; diagnosis.